Posted on September 16, 2021
The new version of InSyBio Suite includes InSyBio Pipelines, a new tool for automatizing and optimizing the computational process for identifying biomarkers.
The CEO of InSyBio, Labros Digonis, stated that “This new version of InSyBio Suite overcomes some major limitations of biomedical big data analytics and biomarker discovery and opens the road to establish it as the analysis platform of choice, ‘the SAP’ for Pharma and Nutrition Industries’ R&D. Reproducibility of biomarker discovery is now not a big issue while biomarker discovery and omics data analysis can now be done in a transparent and optimized way differently for the various application domains: Cancer, Neurodegenerative Diseases and Nutrition”.
InSyBio is offering a one-month free license to use InSyBio Suite including the new version of InSyBio Pipelines tool. Request your free trial now by completing a simple form at: https://www.insybio.com/request.html
About InSyBio: InSyBio is an international pioneer bioinformatics revolutionizing the medical field, clinical trials and food/nutrition industries through targeted biomarker discovery and highly-accurate predictive analytics.
Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies, with the means both analytically and computationally to meet their challenging research and innovation goals (such as robust biomarker discovery and accurate predictive models). This is done through a sophisticated, software-as-a-service, machine learning platform which comprehensively integrates multi-omics data reducing the number of samples and additional validation experiments needed. Since 2013, InSyBio has worked with hundreds of academics, large and small companies, hospitals and research centers allowing them to succeed in their biomarker discovery tasks with an increase of at least 10% in predictive accuracy and decrease of at least 80% in overall time and cost.
Visit www.insybio.com to see how InSyBio can help you reach your R&D goals in the era of Precision Medicine and Nutrition.